IBDEI3BJ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1513,0)
 ;;=TOBACCO CESSATION COUNSELING^11^119
 ;;^UTILITY(U,$J,358.4,1514,0)
 ;;=NEUROPSYCH TESTING^3^119
 ;;^UTILITY(U,$J,358.4,1515,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^120
 ;;^UTILITY(U,$J,358.4,1516,0)
 ;;=ANXIETY DISORDERS^2^120
 ;;^UTILITY(U,$J,358.4,1517,0)
 ;;=BIPOLAR & RELATED DISORDERS^3^120
 ;;^UTILITY(U,$J,358.4,1518,0)
 ;;=NEUROCOGNITIVE DISORDERS^17^120
 ;;^UTILITY(U,$J,358.4,1519,0)
 ;;=DEPRESSIVE DISORDERS^7^120
 ;;^UTILITY(U,$J,358.4,1520,0)
 ;;=DISSOCIATIVE DISORDERS ^9^120
 ;;^UTILITY(U,$J,358.4,1521,0)
 ;;=FEEDING & EATING DISORDERS^12^120
 ;;^UTILITY(U,$J,358.4,1522,0)
 ;;=EDUC/OCCUPATIONAL PROBLEMS^10^120
 ;;^UTILITY(U,$J,358.4,1523,0)
 ;;=GENDER DYSPHORIA^14^120
 ;;^UTILITY(U,$J,358.4,1524,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^15^120
 ;;^UTILITY(U,$J,358.4,1525,0)
 ;;=MEDICATION ADVERSE EFFECTS^16^120
 ;;^UTILITY(U,$J,358.4,1526,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^120
 ;;^UTILITY(U,$J,358.4,1527,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^120
 ;;^UTILITY(U,$J,358.4,1528,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^120
 ;;^UTILITY(U,$J,358.4,1529,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^120
 ;;^UTILITY(U,$J,358.4,1530,0)
 ;;=PARAPHILIC DISORDERS^21^120
 ;;^UTILITY(U,$J,358.4,1531,0)
 ;;=PERSONALITY DISORDERS^23^120
 ;;^UTILITY(U,$J,358.4,1532,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^120
 ;;^UTILITY(U,$J,358.4,1533,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^120
 ;;^UTILITY(U,$J,358.4,1534,0)
 ;;=RELATIONAL PROBLEMS^25^120
 ;;^UTILITY(U,$J,358.4,1535,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^120
 ;;^UTILITY(U,$J,358.4,1536,0)
 ;;=SEXUAL DYSFUNCTIONS^27^120
 ;;^UTILITY(U,$J,358.4,1537,0)
 ;;=SLEEP-WAKE DISORDERS^28^120
 ;;^UTILITY(U,$J,358.4,1538,0)
 ;;=SUBSTANCE DISORDER-ALCOHOL^31^120
 ;;^UTILITY(U,$J,358.4,1539,0)
 ;;=SUBSTANCE DISORDER-CANNABIS^33^120
 ;;^UTILITY(U,$J,358.4,1540,0)
 ;;=SUBSTANCE DISORDER-HALLUCINOGEN^34^120
 ;;^UTILITY(U,$J,358.4,1541,0)
 ;;=SUBSTANCE DISORDER-OPIOID^36^120
 ;;^UTILITY(U,$J,358.4,1542,0)
 ;;=SUBSTANCE DISORDER-SEDATIVE/HYPNOTIC^37^120
 ;;^UTILITY(U,$J,358.4,1543,0)
 ;;=SUBSTANCE DISORDER-TOBACCO^39^120
 ;;^UTILITY(U,$J,358.4,1544,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^120
 ;;^UTILITY(U,$J,358.4,1545,0)
 ;;=SUBSTANCE DISORDER-INHALANT^35^120
 ;;^UTILITY(U,$J,358.4,1546,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^120
 ;;^UTILITY(U,$J,358.4,1547,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^120
 ;;^UTILITY(U,$J,358.4,1548,0)
 ;;=DISRUPTIVE,IMPULSE,CONDUCT D/O^8^120
 ;;^UTILITY(U,$J,358.4,1549,0)
 ;;=ELIMINATION DISORDERS^11^120
 ;;^UTILITY(U,$J,358.4,1550,0)
 ;;=GAMBLING DISORDER^13^120
 ;;^UTILITY(U,$J,358.4,1551,0)
 ;;=OTHER MENTAL DISORDERS^20^120
 ;;^UTILITY(U,$J,358.4,1552,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^18^120
 ;;^UTILITY(U,$J,358.4,1553,0)
 ;;=SUBSTANCE DISORDER-CAFFEINE^32^120
 ;;^UTILITY(U,$J,358.4,1554,0)
 ;;=SUICIDAL IDEATIONS/ATTEMPTS^41^120
 ;;^UTILITY(U,$J,358.4,1555,0)
 ;;=SUBSTANCE DISORDER-UNKNOWN SUBSTANCE^40^120
 ;;^UTILITY(U,$J,358.4,1556,0)
 ;;=SUBSTANCE DISORDER-STIMULANTS^38^120
 ;;^UTILITY(U,$J,358.4,1557,0)
 ;;=UNDERDOSING OF MEDICATION REGIMEN^43^120
 ;;^UTILITY(U,$J,358.4,1558,0)
 ;;=OUTPT NEW PATIENT^3^121
 ;;^UTILITY(U,$J,358.4,1559,0)
 ;;=OUTPT ESTABLISHED PATIENT^2^121
 ;;^UTILITY(U,$J,358.4,1560,0)
 ;;=OUTPT CONSULTATIONS^4^121
 ;;^UTILITY(U,$J,358.4,1561,0)
 ;;=NURSING VISIT ONLY^1^121
 ;;^UTILITY(U,$J,358.4,1562,0)
 ;;=INITIAL OBSERVATION^9^121
